The risk or severity of adverse effects can be increased when Ergotamine is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Imatinib. The metabolism of Ambroxol can be decreased when combined with Venlafaxine. The metabolism of Ambroxol can be decreased when combined with Nelfinavir. The metabolism of Ambroxol can be decreased when combined with Ranolazine. The risk or severity of adverse effects can be increased when Methysergide is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Ketoconazole. The metabolism of Ambroxol can be decreased when combined with Darunavir. The serum concentration of Fluvastatin can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Crizotinib. The serum concentration of Cerivastatin can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Diltiazem. The serum concentration of Ibrutinib can be increased when it is combined with Ambroxol. The serum concentration of Ambroxol can be increased when it is combined with Netupitant. The metabolism of Ambroxol can be decreased when combined with Telithromycin. The serum concentration of Ambroxol can be increased when it is combined with Mifepristone. The metabolism of Ambroxol can be decreased when combined with Idelalisib. The metabolism of Ambroxol can be decreased when combined with Boceprevir. The metabolism of Ambroxol can be decreased when combined with Cobicistat. The metabolism of Ambroxol can be increased when combined with Phenobarbital. The serum concentration of Ambroxol can be increased when it is combined with Fosaprepitant. The metabolism of Ambroxol can be decreased when combined with Dihydroergotamine. The serum concentration of Ubidecarenone can be increased when it is combined with Ambroxol. The serum concentration of Ambroxol can be decreased when it is combined with Deferasirox. The metabolism of Ambroxol can be decreased when combined with Ziprasidone. The metabolism of Ambroxol can be increased when combined with Pentobarbital. The risk or severity of adverse effects can be increased when Ambroxol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Metergoline is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Amiodarone. The metabolism of Ambroxol can be decreased when combined with Isavuconazonium. The serum concentration of Simvastatin can be increased when it is combined with Ambroxol. The serum concentration of Ambroxol can be increased when it is combined with Ceritinib. The metabolism of Ambroxol can be increased when combined with Nevirapine. The serum concentration of Ambroxol can be decreased when it is combined with St. John's Wort. The metabolism of Ambroxol can be decreased when combined with Itraconazole. The metabolism of Ambroxol can be decreased when combined with Isradipine. The serum concentration of Ambroxol can be decreased when it is combined with Mitotane. The risk or severity of adverse effects can be increased when Nicergoline is combined with Ambroxol. The metabolism of Ambroxol can be increased when combined with Fosphenytoin. The risk or severity of adverse effects can be increased when Ergonovine is combined with Ambroxol. The serum concentration of Mevastatin can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Bortezomib. The serum concentration of Pravastatin can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be increased when combined with Carbamazepine. The metabolism of Ambroxol can be decreased when combined with Fluconazole. The metabolism of Ambroxol can be decreased when combined with Atazanavir. The metabolism of Ambroxol can be decreased when combined with Rucaparib. The metabolism of Ambroxol can be decreased when combined with Lopinavir. The risk or severity of adverse effects can be increased when Bromocriptine is combined with Ambroxol. The serum concentration of Ambroxol can be decreased when it is combined with Vemurafenib. The metabolism of Ambroxol can be decreased when combined with Dronedarone. The risk or severity of adverse effects can be increased when Lysergic Acid Diethylamide is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Ticlopidine. The metabolism of Ambroxol can be decreased when combined with Cyclosporine. The metabolism of Ambroxol can be increased when combined with Phenytoin. The serum concentration of Rosuvastatin can be increased when it is combined with Ambroxol. The serum concentration of Conivaptan can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Lovastatin. The serum concentration of Pitavastatin can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Fosamprenavir. The metabolism of Ambroxol can be decreased when combined with Fluvoxamine. The serum concentration of Ambroxol can be increased when it is combined with Osimertinib. The risk or severity of adverse effects can be increased when Cabergoline is combined with Ambroxol. The serum concentration of Ambroxol can be increased when it is combined with Aprepitant. The metabolism of Ambroxol can be decreased when combined with Posaconazole. The metabolism of Ambroxol can be decreased when combined with Clarithromycin. The serum concentration of Ambroxol can be increased when it is combined with Ivacaftor. The serum concentration of Ambroxol can be increased when it is combined with Fusidic Acid. The serum concentration of Ambroxol can be increased when it is combined with Stiripentol. The therapeutic efficacy of Ambroxol can be decreased when used in combination with Sarilumab. The metabolism of Ambroxol can be decreased when combined with Olaparib. The metabolism of Ambroxol can be decreased when combined with Clotrimazole. The serum concentration of Bosutinib can be increased when it is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Saquinavir. The metabolism of Ambroxol can be decreased when combined with Sulfisoxazole. The metabolism of Ambroxol can be decreased when combined with Atomoxetine. The serum concentration of Ambroxol can be decreased when it is combined with Dabrafenib. The metabolism of Ambroxol can be increased when combined with Primidone. The serum concentration of Rilpivirine can be increased when it is combined with Ambroxol. The serum concentration of Ambroxol can be decreased when it is combined with Bosentan. The metabolism of Ambroxol can be decreased when combined with Indinavir. The serum concentration of Ambroxol can be decreased when it is combined with Tocilizumab. The metabolism of Ambroxol can be decreased when combined with Delavirdine. The metabolism of Ambroxol can be decreased when combined with Sildenafil. The metabolism of Ambroxol can be increased when combined with Rifapentine. The risk or severity of adverse effects can be increased when Pergolide is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Erythromycin. The serum concentration of Ambroxol can be decreased when it is combined with Enzalutamide. The serum concentration of Ambroxol can be decreased when it is combined with Siltuximab. The serum concentration of Ambroxol can be increased when it is combined with Palbociclib. The metabolism of Ambroxol can be decreased when combined with Voriconazole. The metabolism of Ambroxol can be decreased when combined with Doxycycline. The metabolism of Ambroxol can be decreased when combined with Clemastine. The metabolism of Ambroxol can be decreased when combined with Nefazodone. The metabolism of Ambroxol can be decreased when combined with Nilotinib. The risk or severity of adverse effects can be increased when Methylergometrine is combined with Ambroxol. The serum concentration of Tolvaptan can be increased when it is combined with Ambroxol. The risk or severity of adverse effects can be increased when Lisuride is combined with Ambroxol. The metabolism of Ambroxol can be decreased when combined with Telaprevir. The metabolism of Ambroxol can be increased when combined with Rifampicin. The metabolism of Ambroxol can be decreased when combined with Verapamil. The metabolism of Ambroxol can be increased when combined with Rifabutin. The serum concentration of Ambroxol can be increased when it is combined with Dasatinib. The serum concentration of Ambroxol can be increased when it is combined with Simeprevir. The serum concentration of Ambroxol can be increased when it is combined with Luliconazole. The metabolism of Ambroxol can be increased when combined with Lumacaftor.